News

AI-powered quantification of bone metastasis in prostate cancer

Prostate cancer is the second most common cancer among men, and there are now effective treatments for the disease. New therapies available on the market for treating prostate-cancer metastasis can improve symptoms and prolong life. However, these drugs are often cost-prohibitive.  Hence, in order to…

Radiomics – the next era of possibilities in Precision Medicine

Traditionally medical image analysis has been done through visual interpretation of static images. In the past decade, with the advent of sophisticated measurement tools, it has become possible to convert simple digital images into data mines which contain first, second and higher-order statistics. When administered…

Radiologist’s AI-powered workflow

We all have been exposed to the riveting news of artificial intelligence tools taking over diagnostic imaging. Due to the rapid increase in global drivers such as aging population, new government initiatives and growing imaging technology, there is a pressing need to address the increased…

Seamless integration of mint Lesion and AGFA ORBIS RIS

At this year’s Radiological Society of North America (RSNA) Annual Meeting 2018, Agfa HealthCare and Mint Medical will announce a seamless integration of ORBIS RIS and mint Lesion™ – a platform for structured image-based reporting. This integration is a major improvement of the interaction of…

Mint PI-RADS v2 report as standard for communication with urologists

Since the beginning of 2017, all PI-RADS v2 reads are exclusively performed with mint Lesion by PD Dr. Matthias Röthke, Chief Medical Officer at Conradia in Hamburg (see exemplary Mint report here). In this interview he outlines the challenges of prostate cancer assessment and how Mint…

Pancreas staging in clinical routine at University Hospital Innsbruck

The University Hospital in Innsbruck, Austria, has been using mint Lesion since mid-2015 with the initial focus on clinical trials in order to guarantee the conformity with the guidelines defined in the trial protocol, especially with regards to the requested criteria like RECIST 1.1. With…

Assessment time halved: Importance of a good tumor response assessment tool in clinical site reads

The Clinical Research Imaging Core (CRIC) of the University of Wisconsin Carbone Cancer Center (UWCCC) recently published a poster at the AACI CRI conference titled “Shared Investment to Build a Strong, Streamlined, and Accessible RECIST Foundation in Clinical Research”. On this poster, core manager Mr….

Mint’s US growth continues – Ms. Andjela Azabagic joins Mint Medical

Mint Medical is further boosting the US business and announces the addition of Andjela Azabagic, as Vice President Business Development, to the US team. Andjela is an experienced business and marketing professional with background in growing domestic and international business and product strategy in the...

Research with Mint: Pilot study shows discriminatory power of MRI-based 3D texture analysis for bone lesions

Distinguishing between enchondroma, a benign tumor, and low-grade chondrosarcoma, which is a low-aggressivity malignancy, is a frequent challenge, as the lesions are both histologically and radiographically very similar. Given the fact that enchondroma only requires regular follow-up but chondrosarcoma needs surgical resection, differentiating between them...

Study – free text reporting vs. mint Lesion in clinical routine

Free text reporting in the tumor response assessment of radiologic imaging data is common in clinical routine, whereas in clinical trials standardized computer-aided response assessment is already used rather frequently. Juliane Goebel, Julia Hoischen, Carolin Gramsch, Haemi P. Schemuth, Andreas‑Claudius Hoffmann, Lale Umutlu and Kai...